 NEW YORK and DURHAM, N.C., Feb. 02, 2022 GLOBE NEWSWIRE -- Sio Gene Therapies Inc. NASDAQ: SIOX, a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases, today announced that it will present data in an oral platform presentation and two poster presentations at the 18th Annual WORLDSymposiumTM 2022, to be held February 7-11, 2022. 